相关实验视频
Updated: Jul 17, 2026

09:11
A Mouse Model of in Utero Transplantation
Published on: January 27, 2011
怀孕前的炭疫苗接种与美国陆军妇女怀孕和分娩结果之间的关系
Andrew R Wiesen1, Christopher T Littell
1Department of Preventive Medicine, Madigan Army Medical Center, Tacoma, WA 98431, USA. andrew.wiesen@amedd.army.mil
JAMA
|March 26, 2002
概括
炭疫苗接种对生育年龄妇女的怀孕或出生率没有影响. 这项研究发现,在接种炭疫苗后,对生殖健康结果没有不良影响.
科学领域:
- 生殖健康 生殖健康
- 疫苗学 疫苗学 疫苗学
- 流行病学 流行病学
背景情况:
- 有关炭疫苗对生殖健康的潜在影响存在担忧.
- 调查这些问题对于疫苗安全监测至关重要.
研究的目的:
- 评估炭疫苗接种对生育年龄妇女怀孕率的影响.
- 确定炭疫苗接种是否影响出生率和不利的出生结果.
主要方法:
- 一项队列研究使用了17至44岁妇女的数据进行.
- 信息来源于1999年1月至2000年3月期间驻扎在斯图尔特堡和亨特陆军机场的妇女的计算机数据库.
主要成果:
- 在4092名妇女中,3136名妇女接种了炭疫苗.
- 在接种疫苗和未接种疫苗的妇女之间,在怀孕率 (比率比率0.94) 或出生率 (几率比率0.9) 中没有观察到统计学意义上的差异.
- 该研究缺乏足够的功率来检测潜在的不良出生结果.
结论:
- 炭疫苗接种对怀孕率没有不利影响.
- 疫苗没有影响受试群体的出生率或不良出生结果.
相关概念视频
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
In Vitro Fertilization
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...

